ridaura

Generic: auranofin

Labeler: sebela pharmaceuticals inc.
NDC Directory HUMAN PRESCRIPTION DRUG NDA Inactive Finished

Drug Facts

Product Profile

Brand Name ridaura
Generic Name auranofin
Labeler sebela pharmaceuticals inc.
Dosage Form CAPSULE
Routes
ORAL
Active Ingredients

auranofin 3 mg/1

Manufacturer
Sebela Pharmaceuticals Inc.

Identifiers & Regulatory

Product NDC 54766-093
Product ID 54766-093_431445cb-3625-82d8-e063-6394a90aeaea
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category NDA
Application Number NDA018689
Marketing Start 2016-12-15
Marketing End 2027-10-31

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 54766093
Hyphenated Format 54766-093

Supplemental Identifiers

RxCUI
197386 213510
UPC
0354766093067
UNII
3H04W2810V

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name ridaura (source: ndc)
Generic Name auranofin (source: ndc)
Application Number NDA018689 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 3 mg/1
source: ndc
Packaging
  • 60 CAPSULE in 1 BOTTLE (54766-093-06)
source: ndc

Packages (1)

54766-093-06 60 CAPSULE in 1 BOTTLE (54766-093-06)

Ingredients (1)

auranofin (3 mg/1)

Linked Drug Pages (1)

RIDAURA ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "431445cb-3625-82d8-e063-6394a90aeaea", "openfda": {"upc": ["0354766093067"], "unii": ["3H04W2810V"], "rxcui": ["197386", "213510"], "spl_set_id": ["43ba3de1-ab2e-06f6-e054-00144ff8d46c"], "manufacturer_name": ["Sebela Pharmaceuticals Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "60 CAPSULE in 1 BOTTLE (54766-093-06)", "package_ndc": "54766-093-06", "marketing_end_date": "20271031", "marketing_start_date": "20161215"}], "brand_name": "RIDAURA", "product_id": "54766-093_431445cb-3625-82d8-e063-6394a90aeaea", "dosage_form": "CAPSULE", "product_ndc": "54766-093", "generic_name": "auranofin", "labeler_name": "Sebela Pharmaceuticals Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "RIDAURA", "active_ingredients": [{"name": "AURANOFIN", "strength": "3 mg/1"}], "application_number": "NDA018689", "marketing_category": "NDA", "marketing_end_date": "20271031", "marketing_start_date": "20161215"}